R
1.05
0.02 (1.94%)
| Previous Close | 1.03 |
| Open | 1.03 |
| Volume | 224,513 |
| Avg. Volume (3M) | 719,574 |
| Market Cap | 41,375,568 |
| Price / Earnings (Forward) | 59.17 |
| Price / Sales | 0.470 |
| Price / Book | 1.11 |
| 52 Weeks Range | |
| Earnings Date | 26 Mar 2026 |
| Profit Margin | -0.27% |
| Operating Margin (TTM) | -7.19% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -16.60% |
| Total Debt/Equity (MRQ) | 40.82% |
| Current Ratio (MRQ) | 2.95 |
| Operating Cash Flow (TTM) | 3.10 M |
| Levered Free Cash Flow (TTM) | 1.22 M |
| Return on Assets (TTM) | 0.68% |
| Return on Equity (TTM) | -1.01% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Rockwell Medical, Inc. | Mixed | Bearish |
AIStockmoo Score
-0.1
| Analyst Consensus | 2.5 |
| Insider Activity | -3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -0.10 |
|
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 13.81% |
| % Held by Institutions | 20.55% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Panagora Asset Management Inc | 31 Dec 2025 | 67,269 |
| Wealthtrust Axiom Llc | 31 Dec 2025 | 37,900 |
| 52 Weeks Range | ||
| Median | 2.50 (138.10%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 26 Jan 2026 | 2.50 (138.10%) | Buy | 1.09 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHOLE TIMOTHY | - | 0.900 | -2,444 | -2,200 |
| HUNTER HEATHER | - | 0.900 | -2,444 | -2,200 |
| NERI JESSE | - | 0.900 | -2,444 | -2,200 |
| STROBECK MARK | - | 0.900 | -7,333 | -6,600 |
| TIMMINS MEGAN C. | - | 0.900 | -3,667 | -3,300 |
| Aggregate Net Quantity | -18,332 | |||
| Aggregate Net Value ($) | -16,499 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 0.900 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| STROBECK MARK | Officer | 14 Mar 2026 | Disposed (-) | 7,333 | 0.900 | 6,600 |
| CHOLE TIMOTHY | Officer | 14 Mar 2026 | Disposed (-) | 2,444 | 0.900 | 2,200 |
| NERI JESSE | Officer | 14 Mar 2026 | Disposed (-) | 2,444 | 0.900 | 2,200 |
| TIMMINS MEGAN C. | Officer | 14 Mar 2026 | Disposed (-) | 3,667 | 0.900 | 3,300 |
| HUNTER HEATHER | Officer | 14 Mar 2026 | Disposed (-) | 2,444 | 0.900 | 2,200 |
| Date | Type | Details |
|---|---|---|
| 20 Jan 2026 | Announcement | Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results |
| 12 Jan 2026 | Announcement | Rockwell Medical Adds 30 New Customers in the West |
| 05 Jan 2026 | Announcement | Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |